Last reviewed · How we verify

NCT05196451: SIPCOV

Short-time Intervention in Post-Covid Syndrome Syndrome (SIPCOV): A Pragmatic Randomised Controlled Trial

Completed NA Last updated 30 May 2024
What this trial tests

NA trial testing Rehabilitation based on CBT principles in COVID-19 in 314 participants. Completed in 30 April 2024.

Timeline
21 February 2022
Primary endpoint
1 December 2023
30 April 2024

Quick facts

Lead sponsorUniversity Hospital, Akershus
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment314
Start date21 February 2022
Primary completion1 December 2023
Estimated completion30 April 2024
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Akershus

Who can join

16 and older, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study is a 2-arm pragmatic randomised controlled trial (RCT) in which 310 patients who suffer from post-Covid syndrome are randomised to either a short-time outpatient-based rehabilitation program (the intervention) or care as usual in a 1:1 ratio. Assessments will take place immediately before randomisation (T0), after intervention or care as usual (T1), and 6 months after T1 (T2). Patients will be recruited from General Practitioners (GP's) as well as social media and self-referral to the involved institutions.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Brief Outpatient Rehabilitation Program for Post-COVID-19 Condition: A Randomized Clinical Trial.
    Nerli TF, Selvakumar J, Cvejic E, Heier I, et al · · 2024 · cited 18× · PMID 39699896 · DOI 10.1001/jamanetworkopen.2024.50744
  2. Applicability and adaptation of cognitive behavior therapy for long COVID neuropsychiatric symptoms: a review with insights from ME/CFS.
    Takamatsu N, Kuga H. · · 2025 · cited 1× · PMID 41073921 · DOI 10.1186/s12879-025-11754-0
  3. Cost-effectiveness of a brief cognitive-behavioral outpatient rehabilitation program for patients with post-COVID-19 condition within a pragmatic randomized controlled trial.
    Nerli TF, Selvakumar J, Heier I, Johnsen TL, et al · · 2026 · PMID 42032661 · DOI 10.1186/s12962-026-00748-7

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

Other University Hospital, Akershus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05196451.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing